Evidence map›Paper›PMID 33809790›Full record

ArticleMicroorganisms2021

Potentiality of Native Ascomycete Strains in Bioremediation of Highly Polychlorinated Biphenyl Contaminated Soils.

Joaquim Germain, Muriel Raveton, Marie-Noëlle Binet, Bello Mouhamadou

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joaquim GermainLaboratoire d'Ecologie Alpine, UMR 5553 CNRS/USMB Université Grenoble Alpes, CEDEX 9, 38058 Grenoble, France.
Muriel RavetonLaboratoire d'Ecologie Alpine, UMR 5553 CNRS/USMB Université Grenoble Alpes, CEDEX 9, 38058 Grenoble, France.
Marie-Noëlle BinetLaboratoire d'Ecologie Alpine, UMR 5553 CNRS/USMB Université Grenoble Alpes, CEDEX 9, 38058 Grenoble, France.
Bello MouhamadouLaboratoire d'Ecologie Alpine, UMR 5553 CNRS/USMB Université Grenoble Alpes, CEDEX 9, 38058 Grenoble, France.

Funding

Agence de l'Environnement et de la Maîtrise de l'Energie Thèse ADEMECentre National de la Recherche Scientifique Projet Prématuration
6 · The paper itself

Abstract

Polychlorinated biphenyls (PCBs) are organic pollutants that are harmful to environment and toxic to humans. Numerous studies, based on basidiomycete strains, have reported unsatisfactory results in the mycoremediation of PCB-contaminated soils mainly due to the non-telluric origin of these strains. The abilities of a five-Ascomycete-strain consortium in the mycoremediation of PCB-polluted soils and its performance to restore their sound functioning were investigated using mesocosm experiments associated with chromatography gas analysis and enzymatic activity assays. With the soil H containing 850 ppm PCB from which the strains had been isolated, a significant PCB depletion of 29% after three months of treatment was obtained. This led to an important decrease of PCBs from 850 to 604 ppm. With the soil L containing 36 ppm PCB, biodegradation did not occur. In both soils, the fungal biomass quantified by the ergosterol assay, did not increase at the end of the treatment. Biodegradation evidenced in the soil H resulted in a significantly improved stoichiometry of N and P acquiring enzymatic activities. This unprecedented study demonstrates that the native Ascomycetes display remarkable properties for remediation and restoration of functioning of the soil they originated from paving the way for greater consideration of these strains in mycoremediation.

Indexed as

bioaugmentationmycoremediationnative AscomycetesPCBssoil functioning

Identifiers

PMID33809790
PMCPMC8002370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.